<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/031518</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;031518</article-id><article-id pub-id-type="other" hwp:sub-type="slug">031518</article-id><article-id pub-id-type="other" hwp:sub-type="tag">031518</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Genomics" hwp:journal="biorxiv"><subject>Genomics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Human knockouts in a cohort with a high rate of consanguinity</article-title></title-group><author-notes hwp:id="author-notes-1"><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2 xref-fn-1-3 xref-fn-1-4 xref-fn-1-5 xref-fn-1-6"><label>†</label><p hwp:id="p-1">Contributed equally</p></fn><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2"><label>*</label><bold>Corresponding authors:</bold> Danish Saleheen, MBBS, PhD Department of Biostatistics and Epidemiology University of Pennsylvania 11–134 Translational Research Center3400 Civic Center Boulevard Philadelphia, PA 19104 Tel: 215–573–6323 Fax: 215–573–2094 Email: <email hwp:id="email-1">saleheen@mail.med.upenn.edu</email> Sekar Kathiresan, MD Broad Institute and Massachusetts General Hospital CPZN 5.252 185 Cambridge Street Boston, MA 02114 Tel: 617–643–6120 Email: <email hwp:id="email-2">sekar@broadinstitute.org</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Saleheen Danesh"><surname>Saleheen</surname><given-names>Danesh</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">†</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Natarajan Pradeep"><surname>Natarajan</surname><given-names>Pradeep</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">†</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-3"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Zhao Wei"><surname>Zhao</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-4"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Rasheed Asif"><surname>Rasheed</surname><given-names>Asif</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-5"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Khetarpal Sumeet"><surname>Khetarpal</surname><given-names>Sumeet</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-6"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Won Hong-Hee"><surname>Won</surname><given-names>Hong-Hee</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-7"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Karczewski Konrad J."><surname>Karczewski</surname><given-names>Konrad J.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-3" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-8"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="O’Donnell-Luria Anne H"><surname>O’Donnell-Luria</surname><given-names>Anne H</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-4" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-9"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Samocha Kaitlin E."><surname>Samocha</surname><given-names>Kaitlin E.</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-3" hwp:rel-id="aff-6">6</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-10"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Gupta Namrata"><surname>Gupta</surname><given-names>Namrata</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-5" hwp:rel-id="aff-4">4</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-11"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Zaidi Mozzam"><surname>Zaidi</surname><given-names>Mozzam</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-12"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Samuel Maria"><surname>Samuel</surname><given-names>Maria</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-4" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-13"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Imran Atif"><surname>Imran</surname><given-names>Atif</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-5" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-14"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Abbas Shahid"><surname>Abbas</surname><given-names>Shahid</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-15"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Majeed Faisal"><surname>Majeed</surname><given-names>Faisal</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-6" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-16"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Ishaq Madiha"><surname>Ishaq</surname><given-names>Madiha</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-7" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-17"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Akhtar Saba"><surname>Akhtar</surname><given-names>Saba</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-8" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-18"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Trindade Kevin"><surname>Trindade</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-19"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Mucksavage Megan"><surname>Mucksavage</surname><given-names>Megan</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-3" hwp:rel-id="aff-5">5</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-20"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Qamar Nadeem"><surname>Qamar</surname><given-names>Nadeem</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-21"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Zaman Khan Shah"><surname>Zaman</surname><given-names>Khan Shah</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-2" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-22"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Yaqoob Zia"><surname>Yaqoob</surname><given-names>Zia</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-3" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-23"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Saghir Tahir"><surname>Saghir</surname><given-names>Tahir</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-4" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-24"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Rizvi Syed Nadeem Hasan"><surname>Rizvi</surname><given-names>Syed Nadeem Hasan</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-5" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-25"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Memon Anis"><surname>Memon</surname><given-names>Anis</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-6" hwp:rel-id="aff-9">9</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-26"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Mallick Nadeem Hayyat"><surname>Mallick</surname><given-names>Nadeem Hayyat</given-names></name><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-27"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Ishaq Mohammad"><surname>Ishaq</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-1" hwp:rel-id="aff-11">11</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-28"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Rasheed Syed Zahed"><surname>Rasheed</surname><given-names>Syed Zahed</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-2" hwp:rel-id="aff-11">11</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-29"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Memon Fazal-ur-Rehman"><surname>Memon</surname><given-names>Fazal-ur-Rehman</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-1" hwp:rel-id="aff-12">12</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-30"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Mahmood Khalid"><surname>Mahmood</surname><given-names>Khalid</given-names></name><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-1" hwp:rel-id="aff-13">13</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-31"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Ahmed Naveeduddin"><surname>Ahmed</surname><given-names>Naveeduddin</given-names></name><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-1" hwp:rel-id="aff-14">14</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-32"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Do Ron"><surname>Do</surname><given-names>Ron</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-1" hwp:rel-id="aff-15">15</xref><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-1" hwp:rel-id="aff-16">16</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-33"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="MacArthur Daniel G."><surname>MacArthur</surname><given-names>Daniel G.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-6" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-4" hwp:rel-id="aff-6">6</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-34"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Gabriel Stacey"><surname>Gabriel</surname><given-names>Stacey</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-7" hwp:rel-id="aff-4">4</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-35"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Lander Eric S."><surname>Lander</surname><given-names>Eric S.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-8" hwp:rel-id="aff-4">4</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-36"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Daly Mark J."><surname>Daly</surname><given-names>Mark J.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-9" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-5" hwp:rel-id="aff-6">6</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-37"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Frossard Philippe"><surname>Frossard</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-9" hwp:rel-id="aff-2">2</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-3" hwp:rel-id="fn-1">†</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-38"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Danesh John"><surname>Danesh</surname><given-names>John</given-names></name><xref ref-type="aff" rid="a17" hwp:id="xref-aff-17-1" hwp:rel-id="aff-17">17</xref><xref ref-type="aff" rid="a18" hwp:id="xref-aff-18-1" hwp:rel-id="aff-18">18</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-4" hwp:rel-id="fn-1">†</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" hwp:id="contrib-39"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Rader Daniel J."><surname>Rader</surname><given-names>Daniel J.</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-4" hwp:rel-id="aff-5">5</xref><xref ref-type="aff" rid="a19" hwp:id="xref-aff-19-1" hwp:rel-id="aff-19">19</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-5" hwp:rel-id="fn-1">†</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-40"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8402-7435</contrib-id><name name-style="western" hwp:sortable="Kathiresan Sekar"><surname>Kathiresan</surname><given-names>Sekar</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-10" hwp:rel-id="aff-4">4</xref><xref ref-type="author-notes" rid="n1" hwp:id="xref-fn-1-6" hwp:rel-id="fn-1">†</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-8402-7435"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania</institution>, Philadelphia, PA, <country>USA</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3 xref-aff-2-4 xref-aff-2-5 xref-aff-2-6 xref-aff-2-7 xref-aff-2-8 xref-aff-2-9"><label>2</label><institution hwp:id="institution-2">Center for Non-Communicable Diseases</institution>, Karachi, <country>Pakistan</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3"><label>3</label><institution hwp:id="institution-3">Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital</institution>, Boston, MA, <country>USA</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2 xref-aff-4-3 xref-aff-4-4 xref-aff-4-5 xref-aff-4-6 xref-aff-4-7 xref-aff-4-8 xref-aff-4-9 xref-aff-4-10"><label>4</label><institution hwp:id="institution-4">Broad Institute of Harvard and MIT</institution>, Cambridge, MA, <country>USA</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2 xref-aff-5-3 xref-aff-5-4"><label>5</label><institution hwp:id="institution-5">Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania</institution>, Philadelphia, PA, <country>USA</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2 xref-aff-6-3 xref-aff-6-4 xref-aff-6-5"><label>6</label><institution hwp:id="institution-6">Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School</institution>, Boston, <country>MA</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1"><label>7</label><institution hwp:id="institution-7">Division of Genetics and Genomics, Boston Children’s Hospital</institution>, Boston, MA, <country>USA</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">Faisalabad Institute of Cardiology</institution>, Faisalabad, <country>Pakistan</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1 xref-aff-9-2 xref-aff-9-3 xref-aff-9-4 xref-aff-9-5 xref-aff-9-6"><label>9</label><institution hwp:id="institution-9">National Institute of Cardiovascular Disorders</institution>, Karachi, <country>Pakistan</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1"><label>10</label><institution hwp:id="institution-10">Punjab Institute of Cardiology</institution>, Lahore, <country>Pakistan</country></aff><aff id="a11" hwp:id="aff-11" hwp:rev-id="xref-aff-11-1 xref-aff-11-2"><label>11</label><institution hwp:id="institution-11">Karachi Institute of Heart Diseases</institution>, Karachi, <country>Pakistan</country></aff><aff id="a12" hwp:id="aff-12" hwp:rev-id="xref-aff-12-1"><label>12</label><institution hwp:id="institution-12">Red Crescent Institute of Cardiology</institution>, Hyderabad, <country>Pakistan</country></aff><aff id="a13" hwp:id="aff-13" hwp:rev-id="xref-aff-13-1"><label>13</label><institution hwp:id="institution-13">The Civil Hospital</institution>, Karachi, <country>Pakistan</country></aff><aff id="a14" hwp:id="aff-14" hwp:rev-id="xref-aff-14-1"><label>14</label><institution hwp:id="institution-14">Liaquat National Hospital</institution>, Karachi, <country>Pakistan</country></aff><aff id="a15" hwp:id="aff-15" hwp:rev-id="xref-aff-15-1"><label>15</label><institution hwp:id="institution-15">Department of Genetics and Genomic Sciences, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai</institution>, New York, NY, <country>USA</country></aff><aff id="a16" hwp:id="aff-16" hwp:rev-id="xref-aff-16-1"><label>16</label><institution hwp:id="institution-16">The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai</institution>, New York, NY, <country>USA</country></aff><aff id="a17" hwp:id="aff-17" hwp:rev-id="xref-aff-17-1"><label>17</label><institution hwp:id="institution-17">Department of Public Health and Primary Care, University of Cambridge</institution>, <country>UK</country></aff><aff id="a18" hwp:id="aff-18" hwp:rev-id="xref-aff-18-1"><label>18</label><institution hwp:id="institution-18">Wellcome Trust Sanger Institute</institution>, Hinxton, Cambridge, <country>UK</country></aff><aff id="a19" hwp:id="aff-19" hwp:rev-id="xref-aff-19-1"><label>19</label><institution hwp:id="institution-19">Department of Human Genetics, University of Pennsylvania</institution>, <country>USA</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2015"><year>2015</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2015-11-12T13:12:14-08:00">
    <day>12</day><month>11</month><year>2015</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2015-11-12T13:12:14-08:00">
    <day>12</day><month>11</month><year>2015</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2015-11-12T13:51:19-08:00">
    <day>12</day><month>11</month><year>2015</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2015-11-12T13:51:19-08:00">
    <day>12</day><month>11</month><year>2015</year>
  </pub-date><elocation-id>031518</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2015-11-12"><day>12</day><month>11</month><year>2015</year></date>
<date date-type="accepted" hwp:start="2015-11-12"><day>12</day><month>11</month><year>2015</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2015, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2015</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-2">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="031518.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/031518v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="031518.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/031518v1/031518v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/031518v1/031518v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Summary</title><p hwp:id="p-3">A major goal of biomedicine is to understand the function of every gene in the human genome.<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref></sup> Null mutations can disrupt both copies of a given gene in humans and phenotypic analysis of such ‘human knockouts’ can provide insight into gene function. To date, comprehensive analysis of genes knocked out in humans has been limited by the fact that null mutations are infrequent in the general population and so, observing an individual homozygous null for a given gene is exceedingly rare.<sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>,<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup> However, consanguineous unions are more likely to result in offspring who carry homozygous null mutations. In Pakistan, consanguinity rates are notably high.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup> Here, we sequenced the protein-coding regions of 7,078 adult participants living in Pakistan and performed phenotypic analysis to identify homozygous null individuals and to understand consequences of complete gene disruption in humans. We enumerated 36,850 rare (&lt;1 % minor allele frequency) null mutations. These homozygous null mutations led to complete inactivation of 961 genes in at least one participant. Homozygosity for null mutations at <italic toggle="yes">APOC3</italic> was associated with absent plasma apolipoprotein C-III levels; at <italic toggle="yes">PLAG27,</italic> with absent enzymatic activity of soluble lipoprotein-associated phospholipase A2; at <italic toggle="yes">CYP2F1,</italic> with higher plasma interleukin-8 concentrations; and at either <italic toggle="yes">A3GALT2</italic> or <italic toggle="yes">NRG4,</italic> with markedly reduced plasma insulin C-peptide concentrations. After physiologic challenge with oral fat, <italic toggle="yes">APOC3</italic> knockouts displayed marked blunting of the usual post-prandial rise in plasma triglycerides compared to wild-type family members. These observations provide a roadmap to understand the consequences of complete disruption of a large fraction of genes in the human genome.</p></abstract><counts><page-count count="41"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Main Text</title><p hwp:id="p-4">We studied adult participants in the Pakistan Risk of Myocardial Infarction Study (PROMIS) designed to understand the determinants of cardiometabolic diseases in South Asians.<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref></sup> Consanguineous marriages have been common in this region of South Asia for many generations.<sup><xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref></sup> In PROMIS, 38.3% of participants reported that their parents were cousins and 38.1% reported themselves being married to a cousin. An expectation from consanguinity is long regions of autozygosity, defined as homozygous loci identical by descent.<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref></sup> Using genome-wide genotyping data available in 17,744 PROMIS participants, we quantified the length of runs of homozygosity, defined as homozygous segments at least 1.5 megabases long. We compared the lengths of runs of homozygosity among PROMIS participants with that seen in other populations from the International HapMap3 project. Median length of genome-wide homozygosity among PROMIS participants was 6–7 times higher than participants of European (CEU, TSI) (P = 3.6 × 10”<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref></sup>), East Asian (CHB, JPT, CHD) (P = 5.4 × 10<sup>−48</sup>) and African ancestries (YRI, MKK) (P = 1.3 × 10<sup>−40</sup>), respectively (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1</xref></bold>).</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig 1.</label><caption hwp:id="caption-1"><p hwp:id="p-5">PROMIS participants have an excess burden of runs of homozygosity compared with other populations.</p></caption><graphic xlink:href="031518_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-6">In order to characterize the burden of rare homozygous null alleles, we performed whole exome sequencing in 7,078 PROMIS participants (<bold><xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref></bold>). Across all participants, 1,303,689 protein-coding and splice-site sequence variants in 20,008 autosomal genes passed variant quality control metrics. Of these, 47,656 mutations across 13,645 autosomal genes were annotated as null (nonsense, frameshift, or canonical splice-site). To increase the probability that mutations annotated as null are <italic toggle="yes">bona fide</italic>, we removed nonsense and frameshift mutations occurring within the last 5% of the transcript and within exons flanked by non-canonical splice sites, splice site mutations at small (&lt;15 bp) introns, at non-canonical splice sites, and where the purported null allele is observed across primates. Common null alleles are less likely to exert strong functional effects as they are less constrained by purifying selection; thus, we limit our analyses in the rest of the manuscript to null mutations with a minor allele frequency (MAF) of &lt; 1%.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-2"><p hwp:id="p-7">Baseline characteristics of exome sequenced study participants.</p></caption><graphic xlink:href="031518_tbl1" position="float" orientation="portrait" hwp:id="graphic-2"/><graphic xlink:href="031518_tbl1a" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><p hwp:id="p-8">Applying these criteria, we generated a set of 36,850 null mutations across 12,131 autosomal genes.<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref></sup> The site-frequency spectrum for these null mutations revealed that the majority was seen only in one or a few individuals (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2</xref></bold>).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig 2.</label><caption hwp:id="caption-3"><p hwp:id="p-9">Null mutations are typically seen in very few individuals.</p></caption><graphic xlink:href="031518_fig2" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-10">We compared the coefficient of inbreeding (F coefficient) in PROMIS participants with that of 15,249 individuals from outbred populations of European or African American ancestry. The F coefficient estimates the excess homozygosity compared with an estimated outbred ancestor. PROMIS participants had a 4-fold higher median inbreeding coefficient compared to outbred populations (0.016 v 0.0041; <italic toggle="yes">P</italic> &lt; 2 × 10<sup>−16</sup>) (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3A</xref></bold>). Additionally, those in PROMIS who reported that their parents were closely related had even higher median inbreeding coefficients than those who did not (0.024 v 0.013; <italic toggle="yes">P</italic> &lt; 2 × 10<sup>−16</sup>).</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig. 3.</label><caption hwp:id="caption-4"><p hwp:id="p-11">Homozygous null burden in PROMIS is driven by excess autozygosity.</p></caption><graphic xlink:href="031518_fig3" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-12">Across all 7,078 PROMIS participants, both copies of 961 distinct genes were disrupted due to null mutations with MAF &lt; 1%. A full listing of all 961 genes knocked out, the number of knockout participants for each gene, and the specific null mutation(s) are provided in <bold>Supplementary Table 1</bold>. 697 (72.5 %) of the genes were knocked out only in one participant (<bold>Supplementary Figure 1</bold>). About 1 in 5 sequenced participants (1,306 individuals, 18.4 %) had at least one gene knocked by a homozygous null mutation with MAF &lt; 1%. 1,081 of these 1,306 individuals (82.8 %) had complete deficiency for one gene, but a minority of participants were knockouts for more than one gene and one participant had six genes completely inactivated. The F inbreeding coefficient was correlated with the number of homozygous null genes present in each individual. (Spearman r = 0.29; <italic toggle="yes">P</italic> = 3 × 10<sup>−133</sup>) (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3B</xref></bold>).</p><p hwp:id="p-13">We tested the hypothesis that genes observed in the homozygous null state in PROMIS participants are under less evolutionary constraint. We calculated the probability of being loss-of-function intolerant (at &gt;90% threshold) for each gene (see Methods) <sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>,<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref></sup> and. compared this to 961 randomly selected genes. The observed 961 homozygous null genes were less likely to be classified as highly constrained (odds ratio 0.10; 95% CI 0.095, 0.11; P &lt; 1 × 10<sup>−10</sup>).</p><p hwp:id="p-14">We next sought to understand the phenotypic consequences of complete disruption of any of these 961 genes. We applied two approaches. First, for 264 genes where two or more participants were homozygous null, we conducted an association screen against a panel of 201 phenotypic traits (<bold>Supplementary Table 2</bold>). Second, at a single gene, we recalled participants based on genotype across three classes (‘wild-type’, heterozygous null, and homozygous null) and performed provocative physiologic testing.</p><p hwp:id="p-15">At 264 genes where two or more participants were homozygous null, we performed association analyses to determine whether homozygous null mutation status was associated with variation in any of 201 traits. For quantitative traits, we compared mean trait values in homozygous null carriers with non-carriers. For dichotomous traits, we performed logistic regression with trait status as the outcome variable and homozygous null carrier status as the predictor variable. Details of covariate adjustments are presented in the Methods. Across quantitative and dichotomous traits, this resulted in the analysis of 15,263 gene-trait pairs and thus, we set Bonferroni-adjusted significance threshold at <italic toggle="yes">P</italic> = 3 × 10<sup>−6</sup>.</p><p hwp:id="p-16">The quantile-quantile plot of expected versus observed association results shows an excess of highly significant results without systematic inflation (<bold>Supplementary Figure 2</bold>). Association results surpassed the Bonferroni significance threshold for 14 gene-trait pairs (<bold>Supplementary Table 3</bold>). Below, we highlight four associations demonstrating examples of 1) confirmed biochemical deficiency with two independent assays (<italic toggle="yes">PLA2G7</italic>), 2) gene-biomarker association (<italic toggle="yes">CYP2F1</italic>), 3) pure recessive model of association (<italic toggle="yes">A3GALT2</italic>), and 4) confirmed biochemical deficiency with gene-biomarker association (<italic toggle="yes">APOC3</italic>).</p><p hwp:id="p-17">Lipoprotein-associated phospholipase A2 (Lp-PLA2, encoded by <italic toggle="yes">PLA2G7</italic>) hydrolyzes oxidatively-modified polyunsaturated fatty acids producing lysophosphatidylcholine and oxidized nonesterified fatty acids. Higher soluble Lp-PLA2 activity has been correlated with higher risk for cardiovascular disease.<sup><xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref></sup> At <italic toggle="yes">PLA2G7,</italic> we identified two participants homozygous for <italic toggle="yes">PLA2G7</italic> c.663+1G&gt;A. When compared with non-carriers, c.663+1G&gt;A homozygotes have markedly lower Lp-PLA2 enzyme as well as activity (−266 ng/ml, <italic toggle="yes">P</italic> = 7 × 10<sup>−5</sup> for mass; −245 nmol/ml/min, <italic toggle="yes">P</italic> = 2 × 10<sup>−7</sup> for activity) whereas the 102 heterozygotes had an intermediate effect (−107 ng/ml, <italic toggle="yes">P</italic> = 4 × 10<sup>−26</sup> for mass; −115 nmol/ml/min, <italic toggle="yes">P</italic> = 3 × 10<sup>−58</sup> for activity) (<bold>Supplementary Figure 3a-b</bold>).</p><p hwp:id="p-18">Cytochrome P450 2F1 (encoded by <italic toggle="yes">CYP2F1</italic>) is primarily expressed in the lung and metabolizes pulmonary-selective toxins, such as cigarette smoke, and thus, modulates the expression of environmentally-associated pulmonary diseases.<sup><xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref></sup> At <italic toggle="yes">CYP2F1,</italic> we identified two participants homozygous for a splice-site mutation, c.1295–2A&gt;G. When compared with non-carriers, c.1295–2A&gt;G homozygotes displayed higher soluble interleukin 8 concentrations (+40.3 %; <italic toggle="yes">P</italic> = 3 × 10<sup>−6</sup>) (<bold>Supplementary Figure 4</bold>). <italic toggle="yes">CYP2F1</italic> c.1295–2A&gt;G heterozygotes (n = 3 assayed for interleukin 8) had a more modest effect (+10.7 %; <italic toggle="yes">P</italic> = 2 × 10<sup>−4</sup>). Interleukin 8 is a mediator of acute pulmonary inflammation.<sup><xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref></sup></p><p hwp:id="p-19">Alpha-1,3-galactosyltransferase 2 (encoded by <italic toggle="yes">A3GALT2</italic>) catalyzes the formation of the Gal-<italic toggle="yes">α</italic>1–3Galβ1–4GlcNAc-R (<italic toggle="yes">α</italic>-gal) epitope; the biological role of this enzyme in humans is uncertain.<sup><xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref></sup> At <italic toggle="yes">A3GALT2,</italic> we identified two participants homozygous for a frameshift mutation, p.Thr106SerfsTer4. Compared with non-carriers, p.Thr106SerfsTer4 homozygotes had both reduced fasting insulin C-peptide (−97.4%; <italic toggle="yes">P</italic> = 6 × 10<sup>−12</sup>) as well as total fasting insulin concentrations (−91.9%; <italic toggle="yes">P</italic> = 1 × 10<sup>−4</sup>). Such an association was only observed in the homozygous state (<bold>Supplementary Figure 5</bold>). <italic toggle="yes">A3galt<sup>-/-</sup></italic> mice and pigs have recently been shown to have glucose intolerance.<sup><xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>,<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref></sup></p><p hwp:id="p-20">To understand if the identification of only a single homozygote in PROMIS may still be informative, we performed a complementary analysis, focusing on those with the most extreme standard Z scores (|Z score| &gt; 5) and requiring that there be evidence for association in heterozygotes as well (see Methods). This procedure highlighted neureglin 4 (NRG4), a member of the epidermal growth factor family extracellular ligands which is highly expressed in brown fat, particularly during adipocyte differentiation.<sup><xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>,<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref></sup> At <italic toggle="yes">NRG4,</italic> we identified a single participant homozygous for a frameshift mutation, p.Ile75AsnfsTer23, who had nearly absent fasting insulin C-peptide concentrations (−99.3 %; <italic toggle="yes">P</italic> = 7 × 10<sup>−11</sup>). When compared with non-carriers, heterozygotes for <italic toggle="yes">NRG4</italic> p.Ile75AsnfsTer23 (n = 7) displayed 54.5 % reduction in insulin C-peptide (<italic toggle="yes">P</italic> = 6 × 10<sup>−3</sup>). Mice homozygous deleted for <italic toggle="yes">Nrg4</italic> have recently been shown to have glucose intolerance.<sup><xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">18</xref></sup></p><p hwp:id="p-21">Apolipoprotein C-III (apoC-III, encoded by <italic toggle="yes">APOC3</italic>) is a major protein component of chylomicrons, very low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol.<sup><xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref></sup> We and others recently reported that null mutations in heterozygous form lower plasma triglycerides as well as risk for coronary heart disease.<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>,<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup> In both published studies, no <italic toggle="yes">APOC3</italic> homozygotes were identified despite study of nearly 200,000 participants from the U.S. and Europe. However, in this study of about 7,000 Pakistanis, we identified four participants homozygous for <italic toggle="yes">APOC3</italic> p.Arg19Ter. When compared with non-carriers, p.Arg19Ter homozygotes displayed near-absent plasma apoC-III protein (−89.4 %, <italic toggle="yes">P</italic> = 5 × 10<sup>−24</sup>), lower plasma triglyceride concentrations (−61.7 %, <italic toggle="yes">P</italic> = 4 × 10<sup>−4</sup>), higher high-density lipoprotein (HDL) cholesterol (+28.1 mg/dL, <italic toggle="yes">P</italic> = 6 × 10<sup>−9</sup>); and similar levels of low-density lipoprotein (LDL) cholesterol (<italic toggle="yes">P</italic> = 0.11) (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4a-d</xref></bold>).</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig 4.</label><caption hwp:id="caption-5"><p hwp:id="p-22"><italic toggle="yes">APOC3</italic> null homozygotes have diminished fasting triglycerides and blunted post-prandial lipemia.</p></caption><graphic xlink:href="031518_fig4" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><p hwp:id="p-23">ApoC-III functions as a brake on the metabolism of dietary fat and thus, the complete lack of this protein should promote handling of ingested fat. The availability of humans completely deficient in APOC3 allowed us to test this hypothesis directly. We re-contacted one homozygous null proband, his wife, and 27 of his first-degree relatives for genotyping and physiologic investigation. Surprisingly, we found that the proband’s wife was also a null homozygote, leading to all nine children being obligate homozygotes (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4e</xref></bold>). In this family, we challenged homozygotes (n = 6) and non-carriers (n = 7) with a 50 g/m<sup>2</sup> oral fat load followed by serial blood testing for six hours. <italic toggle="yes">APOC3</italic> p.Arg19Ter carriers had significantly lower post-prandial triglyceride excursions (triglycerides area under the curve 468.3 mg/dL*6 hours vs 1267.7 mg/dL*6 hours; <italic toggle="yes">P</italic> = 1 × 10<sup>−4</sup>) (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4f</xref></bold>). These data show that complete lack of APOC3 markedly improves clearance of plasma triglycerides after a fatty meal.</p><p hwp:id="p-24">Gene disruption in model organisms followed by phenotypic analysis has been a fruitful approach to understand gene function; here, we extend this concept to the human organism, leveraging naturally-occurring null mutations, consanguinity, and extensive biochemical phenotyping. These results permit several conclusions.</p><p hwp:id="p-25">First, power to identify human knockouts is improved with the study of populations with high degrees of consanguinity. Using the observed median inbreeding coefficient of sequenced participants, we estimate that with the sequencing of 200,000 Pakistanis, about 8,754 genes (95% CI, 8,669–8,834) will be completely knocked out in at least one participant (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig. 5</xref></bold>). In contrast, with the sequencing of a similar number of outbred individuals of European, East Asian, or African American ancestries, the expected number of genes knocked out is much less at 1,382 (95% CI, 1,339−1,452), 1,423 (95% CI, 1,388−1,457), and 1,822 (95% CI, 1,772−1,871), respectively (minor allele frequency estimates obtained from the Exome Aggregation Consortium, manuscript submitted in parallel). Thus, if a similar number of individuals were sequenced across different ancestries, the number of genes completely knocked out would be nearly six-fold higher in Pakistanis when compared with other outbred populations. For example, among &gt;100,000 participants in Iceland, 1107 homozygous null genes were identified whereas we observe nearly the same number of null genes after analysis of about 7,000 Pakistanis.<sup><xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref></sup></p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;031518v1/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig 5.</label><caption hwp:id="caption-6"><p hwp:id="p-26">Simulations anticipate many more homozygous null genes in the PROMIS cohort.</p></caption><graphic xlink:href="031518_fig5" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><p hwp:id="p-27">Second, dense phenotyping can uncover a range of phenotypic consequences from complete disruption of a gene as observed for <italic toggle="yes">PLA2G7, CYP2F1, A3GALT2</italic> and <italic toggle="yes">NRG4.</italic> Third, recall of complete human knockouts followed by provocative testing may provide physiologic insights. We used this approach to demonstrate that complete lack of apolipoprotein C-III is tolerated and results in both lowered fasting triglyceride concentrations as well as blunted post-prandial lipemia. Finally, to date, most human genetic studies have pursued a phenotype-first (“forward” genetics) approach, beginning with traits of interest followed by genetic mapping. Here, we show that it is now possible to pursue a systematic genotype-first (“reverse” genetics) approach, starting with homozygous null humans followed by methodical examination of a diverse set of traits.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3">Methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-4">General overview of the Pakistan Risk for Myocardial Infarction Study (PROMIS)</title><p hwp:id="p-28">The PROMIS study is designed to investigate determinants of cardiometabolic diseases in Pakistan. Since 2005, the study has enrolled close to 38,000 participants; the present investigation included 7,078 participants. Participants aged 30–80 years were enrolled from nine recruitment centers based in five major urban cities in Pakistan. Type 2 diabetes in the study was defined based on self-report or fasting glucose levels &gt;125 mg/dL or HbA1c &gt; 6.5 % or use of glucose lowering medications. The study was approved by the institutional review board at the Center for Non-Communicable Diseases (IRB: 00007048, I0RG0005843, FWAS00014490) and all participants gave informed consent.</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-5">Phenotype descriptions</title><p hwp:id="p-29">Non-fasting blood samples (with the time since last meal recorded) were drawn and centrifuged within 45 minutes of venipuncture. Serum, plasma and whole blood samples were stored at −70°C within 45 minutes of venipuncture. All samples were transported on dry ice to the central laboratory at the Center for Non-Communicable Diseases (CNCD), Pakistan, where serum and plasma samples were aliquoted across 10 different storage vials. Samples were stored at −70°C for any subsequent laboratory analyses. All biochemical assays were conducted in automated auto-analyzers. At CNCD Pakistan, measurements for total-cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and creatinine were made in serum samples using enzymatic assays; whereas levels of HbA1c were measured using a turbidemetric assay in whole-blood samples (Roche Diagnostics, USA). For further measurements, aliquots of serum and plasma samples were transported on dry ice to the Smilow Research Center, University of Pennsylvania, USA, where following biochemical assays were conducted: apolipoproteins (apoA-I, apoA-II, apoB, apoC-III, apoE) and non-esterified fatty acids were measured through immunoturbidometric assays using kits by Roche Diagnostics or Kamiya; lipoprotein (a) levels were determined through a turbidimetric assay using reagents and calibrators from Denka Seiken (Niigata, Japan); LpPLA2 mass and activity levels were determined using immunoassays manufactured by diaDexus (San Francisco, CA, USA); measurements for insulin, leptin and adiponectin were made using radio-immunoassays by LINCO (MO, USA); levels of adhesion molecules (ICAM-1, VCAM-1, P- and E-Selectin) were determined through enzymatic assays by R&amp;D (Minneapolis, MN, USA); and measurements for C-reactive protein, alanine transaminase, aspartate transaminase, cystatin-C, ferritin, ceruloplasmin, thyroid stimulating hormone, alkaline phosphatase, sodium, potassium, choloride, phosphate, sex-harmone binding globulin were made using enzymatic assays manufactured by Abbott Diagnostics (NJ, USA). Glomerular filtration rate (eGFR) was estimated from serum creatinine levels using the MDRD equation. ApoC-III levels were determined in an autoanalyzer using a commercially available ELISA by Sekisui Diagnostics (Lexington, USA). We also measured the following 52 protein biomarkers by multiplex immunoassay using a customised panel on the Luminex 100/200 instrument by RBM (Myriad Rules Based Medicine, Austin, TX, USA): fatty acid binding protein, granuloctye monocyte colony stimulating factor, granulocyte colony stimulating factor, interferon gamma, interleukin-1 beta, interleukin 1 receptor, interleukin 2, interleukin 3, interleukin 4, interleukin 5, interleukin 6, interleukin 7, interleukin 8, interleukin 10, interleukin 18, interleukin p40, interleukin p70, interleukin 15, interleukin 17, interleukin 23, macrophage inflammatory protein 1 alpha, macrophage inflammatory protein 1 beta, malondialdehyde-modified LDL, matrix metalloproteinase 2, matrix metalloproteinase 3, matrix metalloproteinase 9, nerve growth factor beta, tumor necrosis factor alpha, tumor necrosis factor beta, brain-derived neurotrophic factor, CD40, CD40 ligand, eotaxin, factor VII, insulin-like growth factor 1, lecithin-type oxidized LDL receptor 1, monocyte chemoattractant protein 1, myeloperoxidase, N-terminal prohormone of brain natriuretic peptide, neuronal cell adhesion molecule, pregnancy-associated plasma protein A, soluble receptor for advanced glycation end-products, sortilin, stem cell factor, stromal cell-derived factor 1, thrombomodulin, S100 calcium binding protein B, and vascular endothelial growth factor.</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-6">Laboratory methods for array-based genotyping</title><p hwp:id="p-30">As previously described, a genomewide association scan was performed using the Illumina 660 Quad array at the Wellcome Trust Sanger Institute (Hinxton, UK) and using the Illumina HumanOmniExpress at Cambridge Genome Services, UK.<sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup> Initial quality control (QC) criteria included removal of participants or single nucleotide polymorphisms (SNPs) that had a missing rate &gt;5%. SNPs with a MAF &lt;1% and a P-value of &lt;10<sup>−7</sup> for the Hardy-Weinberg equilibrium test were also excluded from the analyses. In PROMIS, further QC included removal of participants with discrepancy between their reported sex and genetic sex determined from the X chromosome. To identify sample duplications, unintentional use of related samples (cryptic relatedness) and sample contamination (individuals who seem to be related to nearly everyone in the sample), identity-by-descent (IBD) analyses were conducted in PLINK.<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup></p></sec><sec id="s2d" hwp:id="sec-6"><title hwp:id="title-7">Laboratory methods for exome sequencing</title><p hwp:id="p-31">Exome sequencing. Exome sequencing was performed at the Broad Institute. Sequencing and exome capture methods have been previously described.<sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>,<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref></sup> A brief description of the methods is provided below.</p><p hwp:id="p-32">Receipt/quality control of sample DNA. Samples were shipped to the Biological Samples Platform laboratory at the Broad Institute of MIT and Harvard (Cambridge, MA, USA). DNA concentration was determined by PicoGreen (Invitrogen; Carlsbad, CA, USA) prior to storage in 2D-barcoded 0.75 ml Matrix tubes at −20 <sup>o</sup>C in the SmaRTStore (RTS, Manchester, UK) automated sample handling system. Initial quality control (QC) on all samples involving sample quantification (PicoGreen), confirmation of high-molecular weight DNA and fingerprint genotyping and gender determination (Illumina iSelect; Illumina; San Diego, CA, USA). Samples were excluded if the total mass, concentration, integrity of DNA or quality of preliminary genotyping data was too low.</p><p hwp:id="p-33"><bold>Library construction</bold>. Library construction was performed as previously described<sup><xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref></sup>, with the following modifications: initial genomic DNA input into shearing was reduced from 3μg to 10–100ng in 50μL of solution. For adapter ligation, Illumina paired end adapters were replaced with palindromic forked adapters, purchased from Integrated DNA Technologies, with unique 8 base molecular barcode sequences included in the adapter sequence to facilitate downstream pooling. With the exception of the palindromic forked adapters, the reagents used for end repair, A-base addition, adapter ligation, and library enrichment PCR were purchased from KAPA Biosciences (Wilmington, MA, USA) in 96-reaction kits. In addition, during the post-enrichment SPRI cleanup, elution volume was reduced to 20 μL to maximize library concentration, and a vortexing step was added to maximize the amount of template eluted.</p><p hwp:id="p-34"><bold>In-solution hybrid selection</bold>. 1,973 samples underwent in-solution hybrid selection as previously described<sup><xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-2" hwp:rel-id="ref-26">26</xref></sup>, with the following exception: prior to hybridization, two normalized libraries were pooled together, yielding the same total volume and concentration specified in the publication. 5,263 samples underwent hybridization and capture using the relevant components of Illumina’s Rapid Capture Exome Kit and following the manufacturer’s suggested protocol, with the following exceptions: first, all libraries within a library construction plate were pooled prior to hybridization, and second, the Midi plate from Illumina’s Rapid Capture Exome Kit was replaced with a skirted PCR plate to facilitate automation. All hybridization and capture steps were automated on the Agilent Bravo liquid handling system.</p><p hwp:id="p-35"><bold>Preparation of libraries for cluster amplification and sequencing</bold>. Following post-capture enrichment, libraries were quantified using quantitative PCR (KAPA Biosystems) with probes specific to the ends of the adapters. This assay was automated using Agilent’s Bravo liquid handling platform. Based on qPCR quantification, libraries were normalized to 2nM and pooled by equal volume using the Hamilton Starlet. Pools were then denatured using 0.1 N NaOH. Finally, denatured samples were diluted into strip tubes using the Hamilton Starlet.</p><p hwp:id="p-36"><bold>Cluster amplification and sequencing</bold>. Cluster amplification of denatured templates was performed according to the manufacturer’s protocol (Illumina) using HiSeq v3 cluster chemistry and HiSeq 2000 or 2500 flowcells. Flowcells were sequenced on HiSeq 2000 or 2500 using v3 Sequencing-by-Synthesis chemistry, then analyzed using RTA v.1.12.4.2. Each pool of whole exome libraries was run on paired 76bp runs, with and 8 base index sequencing read was performed to read molecular indices, across the number of lanes needed to meet coverage for all libraries in the pool.</p><p hwp:id="p-37"><bold>Read mapping and variant discovery</bold>. Samples were processed from real-time base-calls (RTA v.1.12.4.2 software [Bustard], converted to qseq.txt files, and aligned to a human reference (hg19) using Burrows–Wheeler Aligner (BWA).<sup><xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref></sup> Aligned reads duplicating the start position of another read were flagged as duplicates and not analysed. Data was processed using the Genome Analysis ToolKit (GATK v3).<sup><xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>−<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref></sup> Reads were locally realigned around indels and their base qualities were recalibrated. Variant calling was performed on both exomes and flanking 50 base pairs of intronic sequence across all samples using the HaplotypeCaller (HC) tool from the GATK to generate a gVCF. Joint genotyping was subsequently performed and ‘raw’ variant data for each sample was formatted (variant call format (VCF)). SNVs and indel sites were initially filtered after variant calibration marked sites of low quality that were likely false positives.</p><p hwp:id="p-38"><bold>Data analysis QC</bold>. Fingerprint concordance between sequence data and fingerprint genotypes was evaluated. Variant calls were evaluated on both bulk and per-sample properties: novel and known variant counts, transition–transversion (TS–TV) ratio, heterozygous–homozygous non-reference ratio, and deletion/insertion ratio. Both bulk and sample metrics were compared to historical values for exome sequencing projects at the Broad Institute. No significant deviation of from historical values was noted.</p></sec><sec id="s2e" hwp:id="sec-7"><title hwp:id="title-8">Data processing and quality control of exome sequencing</title><p hwp:id="p-39"><bold>Variant annotation</bold>. Variants were annotated using Variant Effect Predictor<sup><xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup> and the LOFTEE<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref></sup> plugin to identify protein-truncating variants predicted to disrupt the respective gene’s function with “high confidence.” Each allele at polyallelic sites was separately annotated.</p><p hwp:id="p-40"><bold>Sample level quality control</bold>. We performed quality control of samples using the following steps. For quality control of samples, we used bi-allelic SNVs that passed the GATK VQSR filter and were on genomic regions targeted by both ICE and Agilent exome captures. We removed samples with discordance rate &gt; 10% between genotypes from exome sequencing with genotypes from array-based genotyping and samples with sex mismatch between inbreeding coefficient on chromosome X and fingerprinting. We tested for sample contamination using the verifyBamID software, which examines the proportion of non-reference bases at reference sites, and excluded samples with high estimated contamination (FREEMIX scores &gt; 0.2).<sup><xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref></sup> After removing monozygotic twins or duplicate samples using the KING software<sup><xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref></sup>, we removed outlier samples with too many or too few SNVs (&gt;17,500 total variants for Agilent-captured samples or &gt;18,000 for ICE-captured samples; &lt;12,000 total variants; &gt;600 singletons; and &gt;400 doubletons). We removed those with extreme overall transition-to-transversion ratios (&gt;4 or &lt;3) and heterozygosity (heterozygote-to-homozygote ratio &gt;6 or &lt;2). Finally, we removed samples with high missingness (&gt;0.05).</p><p hwp:id="p-41"><bold>Variant level quality control</bold>. Variant score quality recalibration was performed separately for SNVs and indels use the GATK VariantRecalibrator and ApplyRecalibration to filter out variants with lower accuracy scores. To further reduce the rate of inaccurate variant calls, we further filtered out SNVs with low average quality (quality per depth of coverage (QD) &lt; 2) and a high degree of missingness (&gt; 20 %), and indels also with low average quality (quality per depth of coverage (QD) &lt; 3) and a high degree of missingness (&gt; 20 %).</p></sec><sec id="s2f" hwp:id="sec-8"><title hwp:id="title-9">Methods for inbreeding analyses</title><p hwp:id="p-42"><bold>Array-derived runs of homozygosity</bold>. Analyses were conducted in PLINK<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref></sup> using genome-wide association (GWAS) data in PROMIS and HapMap 3 populations. Segments of the genome that were at-least 1.5 Mb long, had a SNP density of 1 SNP per 20 kb and had 25 consecutive homozygous SNPs (1 heterozygous and/or 5 missing SNPs were permitted within a segment) were defined to be in a homozygous state (or referred as “runs of homozygosity” (ROH)), as described previously.<sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref></sup> Homozygosity was expressed as the percentage of the autosomal genome found in a homozygous state, and was calculated by dividing the sum of ROH length within each individual by the total length of the autosome in PROMIS and HapMap 3 populations respectively. To investigate variability in homozygosity explained by parental consanguinity, the difference in R<sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-2" hwp:rel-id="ref-2">2</xref></sup> is reported for a linear regression model of homozygosity including and excluding parental consanguinity on top of age, sex and the first 10 principal components derived from the typed autosomal GWAS data.</p><p hwp:id="p-43"><bold>Sequencing-derived coefficient of inbreeding</bold>. We compared the coefficient of inbreeding distributions of 7,078 exome sequenced PROMIS participants with 15,248 participants (European ancestry = 12,849, and African ancestry = 2,399) who were exome sequenced at the Broad Institute (Cambridge, MA) from the Myocardial Infarction Genetics consortium.<sup><xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref></sup> We extracted approximately 5,000 high-quality polymorphic SNVs in linkage equilibrium present on both target intervals that passed variant quality control metrics based on HapMap 3 data.<sup><xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref></sup> Using PLINK, we estimated the coefficient of inbreeding separately within each ethnicity group.<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">23</xref></sup> The coefficient of inbreeding was estimated as the observed degree of homozygosity compared with the anticipated homozygosity derived from an estimated common ancestor.<sup><xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref></sup> The Wilcoxon-Mann-Whitney test was used to test whether PROMIS participants had different median coefficients of inbreeding compared to other similarly sequenced outbred individuals and whether the median coefficient of inbreeding was different between PROMIS participants who reported parental relatedness versus not. A two-sided <italic toggle="yes">P</italic> of 0.05 was the pre-specified threshold for statistical significance.</p></sec><sec id="s2g" hwp:id="sec-9"><title hwp:id="title-10">Methods for sequencing projection analysis</title><p hwp:id="p-44">To compare the burden of unique completely inactivated genes in the PROMIS cohort with outbred cohorts of diverse ethnicities, we extracted the minor allele frequencies (maf) of “high confidence” loss-of-function mutations observed in PROMIS, and in European, African, and East Asian ancestry participants from the Exome Aggregation Consortium (ExAC r0.3; exac.broadinstitute.org). For each gene and for each ethnicity, the combined minor allele frequency (cmaf) of rare (maf &lt; 0.1%) “high confidence” loss-of-function mutations was calculated. We then simulated the number of unique completely inactivated genes across a range of sample sizes per ethnicity and PROMIS. The expected probability of observing complete inactivation (two null copies in an individual) of a gene was calculated as (1 − <italic toggle="yes">F</italic>) * <italic toggle="yes">cmaf</italic> <sup><xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-3" hwp:rel-id="ref-2">2</xref></sup> + <italic toggle="yes">F * cmaf,</italic> which accounts for allozygous and autozygous, respectively, mechanisms for complete genie knockout. F, the inbreeding coefficient, is defined as <italic toggle="yes">F =</italic> 1 − (<italic toggle="yes">expected heterozygosity rate / observed heterozygosity rate</italic>). For PROMIS, the median F inbreeding coefficient (0.016) was used for estimation. Down-sampling within the observed sample size for both high-confidence null mutations and synonymous variants did not deviate significantly from the expected trajectory. For a range of sample sizes (0–200,000), each gene was randomly sampled under a binomial distribution (<italic toggle="yes">X ~ B</italic>(<italic toggle="yes">n, cmaf</italic>)) and it was determined if the gene was successfully sampled at least once. To refine the estimated count of unique genes per sample size, each sampling was replicated ten times.</p></sec><sec id="s2h" hwp:id="sec-10"><title hwp:id="title-11">Methods for constraint score analysis</title><p hwp:id="p-45">We sought to determine whether the observed homozygous null genes were under less evolutionary constraint by first obtaining constraint loss of function constraint scores derived from the Exome Aggregation Consortium (Lek M et al, in preparation).<sup><xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-2" hwp:rel-id="ref-9">9</xref>,<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref></sup> Briefly, we used the number of observed and expected rare (MAF &lt; 0.1%) loss of function variants per gene to determine to which of three classes it was likely to belong: null (observed variation matches expectation), recessive (observed variation is ~50% expectation), or haploinsufficient (observed variation is &lt;10% of expectation). The probability of being loss of function intolerant (pLI) of each transcript was defined as the probability of that transcript falling into the haploinsufficient category. Transcripts with a pLI ≥ 0.9 are considered very likely to be loss of function intolerant; those with pLI ≤ 0.1 are not likely to be loss of function intolerant. A list of 961 genes were randomly sampled from a list of sequenced genes 1,000 times and the proportion of loss of function intolerant genes compared to the proportion of the observed homozygous null genes was compared using the chi square test. The likelihood that the distribution of the test statistics deviated from the null was ascertained.</p></sec><sec id="s2i" hwp:id="sec-11"><title hwp:id="title-12">Methods for rare variant association analysis</title><p hwp:id="p-46"><bold>Recessive model association discovery</bold>. We sought to determine whether complete loss-of-function of a gene was associated with a dense array of phenotypes. We extracted a list of individuals per gene who were homozygous for a high confidence null allele that was rare (minor allele frequency &lt; 1 %) in the cohort. From a list of 961 genes where there was at least one participant homozygous null and a list of 201 traits, we initially considered 192,960 gene-trait pairings. To reduce the likelihood of false positives, we only considered gene-trait pairs where there were at least two homozygous nulls per gene phenotyped for a given trait yielding 15,263 gene-trait pairs for analysis.</p><p hwp:id="p-47">For all analyses, we constructed generalized linear models to test whether complete loss of function versus non-carriers was associated with trait variation. A logit link was used for binomial outcomes. Right-skewed continuous traits were natural log transformed. Age, sex, and myocardial infarction status were used as covariates in all analyses. We extracted principal components of ancestry using EIGENSTRAT to control for population stratification in all analyses.<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref></sup> For lipoprotein-related traits, the use of lipid-lowering therapy was used as a covariate. For glycemic biomarkers, only non-diabetics were used in the analysis. The <italic toggle="yes">P</italic> threshold for statistical significance was 0.05 / 15,263 = 3 × 10<sup>−6</sup>.</p><p hwp:id="p-48"><bold>Heterozygote association replication</bold>. We hypothesized that some of the associations for homozygous nulls will display a more modest effect for heterozygous nulls. Thus, the aforementioned analyses were performed comparing heterozygous nulls to non-carriers for the fourteen homozygous null-trait associations that surpassed prespecified statistical significance. A <italic toggle="yes">P</italic> of 0.05 / 13 = 0.004 was set for statistical significance for these restricted analyses.</p><p hwp:id="p-49"><bold>Association for single genic homozygotes</bold>. We performed an exploratory analysis of gene-trait pairs where there was only one phenotyped homozygous null. We performed the above association analyses for genes where there was only one homozygous null phenotyped for a given trait and we focused on those with the most extreme standard Z score statistics (|Z score| &gt; 5) from the primary association analysis and required that there to also be nominal evidence for association (<italic toggle="yes">P</italic> &lt; 0.05) in heterozygotes as well to maximize confidence in an observed single homozygous null-trait association.</p></sec><sec id="s2j" hwp:id="sec-12"><title hwp:id="title-13">Methods for recruitment and phenotyping of an <italic toggle="yes">APOC3</italic> p.Arg19Ter proband and relatives</title><p hwp:id="p-50"><bold>Methods for Sanger sequencing</bold>. We collected blood samples from a total of 28 subjects, including one of the four <italic toggle="yes">APOC3</italic> p.Arg19Ter homozygous participants along with 27 of his family and community members for DNA extraction and separated into plasma for lipid and apolipoprotein measurements. All subjects were consented prior to initiation of the studies (IRB: 00007048 at the Center for Non-Communicable Diseases, Paksitan). DNA was isolated from whole blood using a reference phenol-chloroform protocol.<sup><xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref></sup> Genotypes for the p.Arg19Ter variant were determined in all 28 participants by Sanger sequencing. A 685 bp region of the <italic toggle="yes">APOC3</italic> gene including the base position for this variant was amplified by PCR (Expand HF PCR Kit, Roche) using the following primer sequences: Forward primer CTCCTTCTGGCAGACCCAGCTAAGG, Reverse primer CCTAGGACTGCTCCGGGGAGAAAG. PCR products were purified with Exo-SAP-IT (Affymetrix) and sequenced via Sanger sequencing using the same primers.</p><p hwp:id="p-51"><bold>Oral fat tolerance test</bold>. Six non-carriers and seven homozygotes also participated in an oral fat tolerance test. Participants fasted overnight and then blood was drawn for measurement of baseline fasted lipids. Following this, participants were administered an oral load of heavy cream (50 g fat per square meter of body surface area as calculated by the method of Mosteller<sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref></sup>). Participants consumed this oral load within a time span of 20 minutes and afterwards consumed 200 mL of water. Blood was drawn at 2, 4, and 6 hours after oral fat consumption as done previously.<sup><xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref></sup> All lipid and apolipoprotein measurements from these plasma samples were determined by immunoturbidimetric assays on an ACE Axcel Chemistry analyzer (Alfa Wasserman). A comparisons of area-under-the curve triglycerides was performed between <italic toggle="yes">APOC3</italic> p.Arg19Ter homozygotes and non-carriers using a two independent sample Student’s t test; <italic toggle="yes">P</italic> &lt; 0.05 was considered statistically significant.</p></sec></sec></body><back><sec hwp:id="sec-13"><p hwp:id="p-52"><bold>Figure Legends</bold></p><p hwp:id="p-53"><bold>Fig 1</bold>. Consanguinity leads to regions of genomic segments that are identical by descent and can be observed as runs of homozygosity. Using genome-wide array data in 17,744 PROMIS participants and reference samples from the International HapMap 3, the burden of runs of homozygosity (minimum 1.5 Mb) per individual was derived and population-specific distributions are displayed, with outliers removed. This highlights the higher median runs of homozygosity burden in PROMIS and the higher proportion of individuals with very high burdens.</p><p hwp:id="p-54"><bold>Fig 2</bold>. The site-frequency spectrum of synonymous, missense, and high-confidence null mutations is represented. Points represent the proportion of variants within a 1 × 10<sup>−4</sup> minor allele frequency bin for each variant category. Lines represent the cumulative proportions of variants categories. The bottom inset highlights that most null variants are often seen in no more than one or two individuals. The top inset highlights that virtually all null mutations are very rare.</p><p hwp:id="p-55"><bold>Fig 3</bold>. <bold>a</bold>, The distribution of F inbreeding coefficient of PROMIS participants is compared to those of outbred samples of African (AFR) and European (EUR) ancestry. <bold>b</bold>, The burden of homozygous null genes per individual is correlated with coefficient of inbreeding.</p><p hwp:id="p-56"><bold>Fig 4</bold>. <bold>a.-d.</bold> Among all sequenced participants, apolipoprotein C-III, triglycerides, HDL cholesterol and LDL cholesterol distributions are displayed by <italic toggle="yes">APOC3</italic> null genotype status. Apolipoprotein C-III concentration is displayed on a logarithmic base 10 scale. <bold>e</bold>. One of the four <italic toggle="yes">APOC3</italic> null homozygotes and several family members were recruited for genotyping <italic toggle="yes">APOC3</italic> p.Arg19Ter. The proband was married to another null homozygote and has nine obligate homozygote children. Given the extensive first-degree unions, the pedigree is simplified for clarity. <bold>f</bold>. <italic toggle="yes">APOC3</italic> p.Arg19Ter homozygotes and non-carriers within the recruited family participated in an oral 50 g/m<sup>2</sup> fat tolerance test. Homozygotes had decreased baseline and post-prandial triglyceride concentrations.</p><p hwp:id="p-57"><bold>Fig 5</bold>. The anticipated number of unique homozygous null genes observed with increasing sample sizes sequenced in PROMIS compared with similar African (AFR) and European (EUR) sample sizes using observed allele frequencies and degree of inbreeding.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-14">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Eisenberg D."><surname>Eisenberg</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marcotte E. M."><surname>Marcotte</surname>, <given-names>E. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xenarios I."><surname>Xenarios</surname>, <given-names>I.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Yeates T. O."><surname>Yeates</surname>, <given-names>T. O.</given-names></string-name> <article-title hwp:id="article-title-2">Protein function in the post-genomic era</article-title>. <source hwp:id="source-1">Nature</source> <volume>405</volume>, <fpage>823</fpage>–<lpage>826</lpage>, doi:<pub-id pub-id-type="doi">10.1038/35015694</pub-id> (<year>2000</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1 xref-ref-2-2 xref-ref-2-3"><label>2</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="MacArthur D. G."><surname>MacArthur</surname>, <given-names>D. G.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-3">A systematic survey of loss-of-function variants in human protein-coding genes</article-title>. <source hwp:id="source-2">Science</source> <volume>335</volume>, <fpage>823</fpage>–<lpage>828</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1215040</pub-id> (<year>2012</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><label>3</label><citation publication-type="other" citation-type="journal" ref:id="031518v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Sulem P."><surname>Sulem</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-4">Identification of a large set of rare complete human knockouts</article-title>. <source hwp:id="source-3">Nat Genet</source>, doi:<pub-id pub-id-type="doi">10.1038/ng.3243</pub-id> (<year>2015</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Bittles A. H."><surname>Bittles</surname>, <given-names>A. H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mason W. M."><surname>Mason</surname>, <given-names>W. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greene J."><surname>Greene</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rao N. A."><surname>Rao</surname>, <given-names>N. A.</given-names></string-name> <article-title hwp:id="article-title-5">Reproductive behavior and health in consanguineous marriages</article-title>. <source hwp:id="source-4">Science</source> <volume>252</volume>, <fpage>789</fpage>–<lpage>794</lpage> (<year>1991</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Saleheen D."><surname>Saleheen</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-6">The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia</article-title>. <source hwp:id="source-5">European Journal of Epidemiology</source> <volume>24</volume>, <fpage>329</fpage>–<lpage>338</lpage>, doi:<pub-id pub-id-type="doi">10.1007/s10654-009-9334-y</pub-id> (<year>2009</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Modell B."><surname>Modell</surname>, <given-names>B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Darr A."><surname>Darr</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-7">Science and society: genetic counselling and customary consanguineous marriage</article-title>. <source hwp:id="source-6">Nat Rev Genet</source> <volume>3</volume>, <fpage>225</fpage>–<lpage>229</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nrg754</pub-id> (<year>2002</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Lander E. S."><surname>Lander</surname>, <given-names>E. S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Botstein D."><surname>Botstein</surname>, <given-names>D.</given-names></string-name> <article-title hwp:id="article-title-8">Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children</article-title>. <source hwp:id="source-7">Science</source> <volume>236</volume>, <fpage>1567</fpage>–<lpage>1570</lpage> (<year>1987</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2"><label>8</label><citation publication-type="website" citation-type="web" ref:id="031518v1.8" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Karczewski K. J."><surname>Karczewski</surname>, <given-names>K. J.</given-names></string-name> <source hwp:id="source-8">LOFTEE (Loss-Of-Function Transcript Effect Estimator)</source>, &lt;<ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/konradjk/loftee" ext-link-type="uri" xlink:href="https://github.com/konradjk/loftee" hwp:id="ext-link-2">https://github.com/konradjk/loftee</ext-link>&gt; (<year>2015</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1 xref-ref-9-2"><label>9</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="De Rubeis S."><surname>De Rubeis</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-9">Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source hwp:id="source-9">Nature</source> <volume>515</volume>, <fpage>209</fpage>–<lpage>215</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature13772</pub-id> (<year>2014</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2"><label>10</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Samocha K. E."><surname>Samocha</surname>, <given-names>K. E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">A framework for the interpretation of de novo mutation in human disease</article-title>. <source hwp:id="source-10">Nat Genet</source> <volume>46</volume>, <fpage>944</fpage>–<lpage>950</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.3050</pub-id> (<year>2014</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Finn A. V."><surname>Finn</surname>, <given-names>A. V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nakano M."><surname>Nakano</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Narula J."><surname>Narula</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kolodgie F. D."><surname>Kolodgie</surname>, <given-names>F. D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Virmani R."><surname>Virmani</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-11">Concept of vulnerable/unstable plaque</article-title>. <source hwp:id="source-11">Arterioscler Thromb Vasc Biol</source> <volume>30</volume>, <fpage>1282</fpage>–<lpage>1292</lpage>, doi:<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.179739</pub-id> (<year>2010</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Carr B. A."><surname>Carr</surname>, <given-names>B. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wan J."><surname>Wan</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hines R. N."><surname>Hines</surname>, <given-names>R. N.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Yost G. S."><surname>Yost</surname>, <given-names>G. S.</given-names></string-name> <article-title hwp:id="article-title-12">Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif</article-title>. <source hwp:id="source-12">The Journal of Biological Chemistry</source> <volume>278</volume>, <fpage>15473</fpage>–<lpage>15483</lpage>, doi:<pub-id pub-id-type="doi">10.1074/jbc.M300319200</pub-id> (<year>2003</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Standiford T. J."><surname>Standiford</surname>, <given-names>T. J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-13">Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung</article-title>. <source hwp:id="source-13">The Journal of Clinical Investigation</source> <volume>86</volume>, <fpage>1945</fpage>–<lpage>1953</lpage>, doi:<pub-id pub-id-type="doi">10.1172/JCI114928</pub-id> (<year>1990</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Christiansen D."><surname>Christiansen</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-14">Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation</article-title>. <source hwp:id="source-14">PLoS Biology</source> <volume>6</volume>, <fpage>e172</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.0060172</pub-id> (<year>2008</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Dahl K."><surname>Dahl</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Buschard K."><surname>Buschard</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gram D. X."><surname>Gram</surname>, <given-names>D. X.</given-names></string-name>, <string-name name-style="western" hwp:sortable="d’Apice A. J."><surname>d’Apice</surname>, <given-names>A. J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hansen A. K."><surname>Hansen</surname>, <given-names>A. K.</given-names></string-name> <article-title hwp:id="article-title-15">Glucose intolerance in a xenotransplantation model: studies in alpha-gal knockout mice</article-title>. <source hwp:id="source-15">APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica</source> <volume>114</volume>, <fpage>805</fpage>–<lpage>811</lpage>, doi:<pub-id pub-id-type="doi">10.1111/j.1600-0463.2006.apm_393.x</pub-id> (<year>2006</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>16</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Casu A."><surname>Casu</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-16">Insulin secretion and glucose metabolism in alpha 1,3-galactosyltransferase knock-out pigs compared to wild-type pigs</article-title>. <source hwp:id="source-16">Xenotransplantation</source> <volume>17</volume>, <fpage>131</fpage>–<lpage>139</lpage>, doi:<pub-id pub-id-type="doi">10.1111/j.1399-3089.2010.00572.x</pub-id> (<year>2010</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Schneider M. R."><surname>Schneider</surname>, <given-names>M. R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wolf E."><surname>Wolf</surname>, <given-names>E.</given-names></string-name> <article-title hwp:id="article-title-17">The epidermal growth factor receptor ligands at a glance</article-title>. <source hwp:id="source-17">Journal of Cellular Physiology</source> <volume>218</volume>, <fpage>460</fpage>–<lpage>466</lpage>, doi:<pub-id pub-id-type="doi">10.1002/jcp.21635</pub-id> (<year>2009</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2"><label>18</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Wang G. X."><surname>Wang</surname>, <given-names>G. X.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-18">The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis</article-title>. <source hwp:id="source-18">Nature Medicine</source> <volume>20</volume>, <fpage>1436</fpage>–<lpage>1443</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nm.3713</pub-id> (<year>2014</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Huff M. W."><surname>Huff</surname>, <given-names>M. W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hegele R. A."><surname>Hegele</surname>, <given-names>R. A.</given-names></string-name> <article-title hwp:id="article-title-19">Apolipoprotein C-III: going back to the future for a lipid drug target</article-title>. <source hwp:id="source-19">Circ Res</source> <volume>112</volume>, <fpage>1405</fpage>–<lpage>1408</lpage>, doi:<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301464</pub-id> (<year>2013</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><collab hwp:id="collab-1">Tg</collab> <etal>et al.</etal> <article-title hwp:id="article-title-20">Loss-of-function mutations in APOC3, triglycerides, and coronary disease</article-title>. <source hwp:id="source-20">N Engl J Med</source> <volume>371</volume>, <fpage>22</fpage>–<lpage>31</lpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1307095</pub-id> (<year>2014</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Jorgensen A. B."><surname>Jorgensen</surname>, <given-names>A. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frikke-Schmidt R."><surname>Frikke-Schmidt</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nordestgaard B. G."><surname>Nordestgaard</surname>, <given-names>B. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Tybjaerg-Hansen A."><surname>Tybjaerg-Hansen</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-21">Loss-of-function mutations in APOC3 and risk of ischemic vascular disease</article-title>. <source hwp:id="source-21">N Engl J Med</source> <volume>371</volume>, <fpage>32</fpage>–<lpage>41</lpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1308027</pub-id> (<year>2014</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Kooner J. S."><surname>Kooner</surname>, <given-names>J. S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci</article-title>. <source hwp:id="source-22">Nat Genet</source> <volume>43</volume>, <fpage>984</fpage>–<lpage>989</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.921</pub-id> (<year>2011</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3"><label>23</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Purcell S."><surname>Purcell</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-23">PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source hwp:id="source-23">American Journal of Human Genetics</source> <volume>81</volume>, <fpage>559</fpage>–<lpage>575</lpage>, doi:<pub-id pub-id-type="doi">10.1086/519795</pub-id> (<year>2007</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Tennessen J. A."><surname>Tennessen</surname>, <given-names>J. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-24">Evolution and functional impact of rare coding variation from deep sequencing of human exomes</article-title>. <source hwp:id="source-24">Science</source> <volume>337</volume>, <fpage>64</fpage>–<lpage>69</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1219240</pub-id> (<year>2012</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2"><label>25</label><citation publication-type="other" citation-type="journal" ref:id="031518v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Do R."><surname>Do</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-25">Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction</article-title>. <source hwp:id="source-25">Nature</source>, doi:<pub-id pub-id-type="doi">10.1038/nature13917</pub-id> (<year>2014</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1 xref-ref-26-2"><label>26</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Fisher S."><surname>Fisher</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-26">A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries</article-title>. <source hwp:id="source-26">Genome Biology</source> <volume>12</volume>, <fpage>R1</fpage>, doi: <pub-id pub-id-type="doi">10.1186/gb-2011-12-1-r1</pub-id> (<year>2011</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Durbin R."><surname>Durbin</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-27">Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source hwp:id="source-27">Bioinformatics</source> <volume>25</volume>, <fpage>1754</fpage>–<lpage>1760</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id> (<year>2009</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><label>28</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="McKenna A."><surname>McKenna</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>. <source hwp:id="source-28">Genome Research</source> <volume>20</volume>, <fpage>1297</fpage>–<lpage>1303</lpage>, doi:<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id> (<year>2010</year>).</citation></ref><ref id="c29" hwp:id="ref-29"><label>29</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="DePristo M. A."><surname>DePristo</surname>, <given-names>M. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-29">A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>. <source hwp:id="source-29">Nat Genet</source> <volume>43</volume>, <fpage>491</fpage>–<lpage>498</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng.806</pub-id> (<year>2011</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Van der Auwera G. A."><surname>Van der Auwera</surname>, <given-names>G. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-30">From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline</article-title>. <source hwp:id="source-30">Current Protocols in Bioinformatics</source> <volume>11</volume>, <fpage>11 10 11</fpage>–<lpage>11 10 33</lpage>, doi:<pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id> (<year>2013</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="McLaren W."><surname>McLaren</surname>, <given-names>W.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-31">Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor</article-title>. <source hwp:id="source-31">Bioinformatics</source> <volume>26</volume>, <fpage>2069</fpage>–<lpage>2070</lpage>, doi: 10.1093/bioinformatics/btq330 (<year>2010</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Jun G."><surname>Jun</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-32">Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data</article-title>. <source hwp:id="source-32">American Journal of Human Genetics</source> <volume>91</volume>, <fpage>839</fpage>–<lpage>848</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.09.004</pub-id> (<year>2012</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Manichaikul A."><surname>Manichaikul</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-33">Robust relationship inference in genome-wide association studies</article-title>. <source hwp:id="source-33">Bioinformatics</source> <volume>26</volume>, <fpage>2867</fpage>–<lpage>2873</lpage>, doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btq559</pub-id> (<year>2010</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Hunter-Zinck H."><surname>Hunter-Zinck</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-34">Population genetic structure of the people of Qatar</article-title>. <source hwp:id="source-34">American Journal of Human Genetics</source> <volume>87</volume>, <fpage>17</fpage>–<lpage>25</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.05.018</pub-id> (<year>2010</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Purcell S. M."><surname>Purcell</surname>, <given-names>S. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-35">A polygenic burden of rare disruptive mutations in schizophrenia</article-title>. <source hwp:id="source-35">Nature</source> <volume>506</volume>, <fpage>185</fpage>–<lpage>190</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nature12975</pub-id> (<year>2014</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Wright S."><surname>Wright</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-36">Coefficients of inbreeding and relationship</article-title>. <source hwp:id="source-36">Am Nat</source> <volume>56</volume>, <fpage>330</fpage>–<lpage>338</lpage> (<year>1922</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2"><label>37</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Price A. L."><surname>Price</surname>, <given-names>A. L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-37">Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source hwp:id="source-37">Nat Genet</source> <volume>38</volume>, <fpage>904</fpage>–<lpage>909</lpage>, doi:<pub-id pub-id-type="doi">10.1038/ng1847</pub-id> (<year>2006</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Sambrook J."><surname>Sambrook</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Russell D. W."><surname>Russell</surname>, <given-names>D. W.</given-names></string-name> <article-title hwp:id="article-title-38">Purification of nucleic acids by extraction with phenol:chloroform</article-title>. <source hwp:id="source-38">CSHprotocols</source> <volume>2006</volume>, doi:<pub-id pub-id-type="doi">10.1101/pdb.prot4455</pub-id> (<year>2006</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Mosteller R. D."><surname>Mosteller</surname>, <given-names>R. D.</given-names></string-name> <article-title hwp:id="article-title-39">Simplified calculation of body-surface area</article-title>. <source hwp:id="source-39">N Engl J Med</source> <volume>317</volume>, <fpage>1098</fpage>, doi:<pub-id pub-id-type="doi">10.1056/NEJM198710223171717</pub-id> (<year>1987</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Maraki M."><surname>Maraki</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-40">Validity of abbreviated oral fat tolerance tests for assessing postprandial lipemia</article-title>. <source hwp:id="source-40">Clinical Nutrition</source> <volume>30</volume>, <fpage>852</fpage>–<lpage>857</lpage>, doi:<pub-id pub-id-type="doi">10.1016/j.clnu.2011.05.003</pub-id> (<year>2011</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41</label><citation publication-type="journal" citation-type="journal" ref:id="031518v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Pollin T. I."><surname>Pollin</surname>, <given-names>T. I.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-41">A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection</article-title>. <source hwp:id="source-41">Science</source> <volume>322</volume>, <fpage>1702</fpage>–<lpage>1705</lpage>, doi:<pub-id pub-id-type="doi">10.1126/science.1161524</pub-id> (<year>2008</year>).</citation></ref></ref-list><sec hwp:id="sec-14"><p hwp:id="p-58"><bold>Supplementary Information</bold> is linked to the online version of the paper at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.nature.com/nature" ext-link-type="uri" xlink:href="http://www.nature.com/nature" hwp:id="ext-link-3">www.nature.com/nature</ext-link>.</p></sec><ack hwp:id="ack-1"><title hwp:id="title-15">Acknowledgements</title><p hwp:id="p-59">Dr. Saleheen is supported by grants from the National Institutes of Health, the Fogarty International, the Wellcome Trust, the British Heart Foundation, and Pfizer. Dr. Natarajan is supported by the John S. LaDue Memorial Fellowship in Cardiology from Harvard Medical School. Dr. Kathiresan is supported by grants from the National Institutes of Health (R01HL107816), the Donovan Family Foundation, and Fondation Leducq. Exome sequencing was supported by a grant from the NHGRI (5U54HG003067–11) to Drs. Gabriel and Lander. Dr. MacArthur is supported by a grant from the National Institutes of Health (R01GM104371). In recognition for PROMIS fieldwork and support, we also acknowledge contributions made by the following: Mohammad Zeeshan Ozair, Usman Ahmed, Abdul Hakeem, Hamza Khalid, Kamran Shahid, Fahad Shuja, Ali Kazmi, Mustafa Qadir Hameed, Naeem Khan, Sadiq Khan, Ayaz Ali, Madad Ali, Saeed Ahmed, Muhammad Waqar Khan, Muhammad Razaq Khan, Abdul Ghafoor, Mir Alam, Riazuddin, Muhammad Irshad Javed, Abdul Ghaffar, Tanveer Baig Mirza, Muhammad Shahid, Jabir Furqan, Muhammad Iqbal Abbasi, Tanveer Abbas, Rana Zulfiqar, Muhammad Wajid, Irfan Ali, Muhammad Ikhlaq, Danish Sheikh, Muhammad Imran, Matthew Walker, Nadeem Sarwar, Sarah Venorman, Robin Young, Adam Butterworth, Hannah Lombardi, Binder Kaur and Nasir Sheikh. Fieldwork in the PROMIS study has been supported through funds available to investigators at the Center for Non-Communicable Diseases, Pakistan and the University of Cambridge, UK.</p></ack><sec hwp:id="sec-15"><title hwp:id="title-16">Author Contributions</title><p hwp:id="p-60">Sample recruitment and phenotyping was performed by D.S., P.F., J.D., A.R., M.Z., M.S., M.F., A.I., N.K.S., S.A., F.M., M.I., S.A., K.T., N.H.M., K.S.Z., N.Q., M.I., S.Z.R., F.M., K.M., and N.A., D.S., P.F., J.D., and W.Z. performed array-based genotyping and runs-of-homozygosity analyses. Exome sequencing was coordinated by D.S., N.G., S.G., E.S.L., D.J.R., and S.K., P.N., W.Z., H.H.W., and R.D. performed exome sequencing quality control and association analyses. P.N., K.J.K., A.H.O., and D.G.M. performed variant annotation. D.S., S.K. and D.J.R. performed confirmatory genotyping and lipoprotein biomarker assays. D.S. and A.R. conducted recall based studies for the APOC3 knockouts. P.N. and M.J.D. performed bioinformatics simulations. P.N. and K.E.S. performed constraint score analyses. D.S., P.N., and S.K. designed the study and wrote the paper. D.S. and P.N. contributed equally. All authors discussed the results and commented on the manuscript.</p></sec><sec hwp:id="sec-16"><p hwp:id="p-61"><bold>Author Information</bold> Summaries of all null variants observed in a homozygous are in the online Supplement. They are additionally, with all observed protein-coding variation, publicly available in the Exome Aggregation Consortium browser (exac.broadinstitute.org). Reprints and permissions information is available at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.nature.com/reprints" ext-link-type="uri" xlink:href="http://www.nature.com/reprints" hwp:id="ext-link-4">www.nature.com/reprints</ext-link>. The authors do not declare competing financial interests. Correspondence and requests for materials should be addressed to D.S. or S.K. (<email hwp:id="email-3">saleheen@mail.med.upenn.edu</email> or <email hwp:id="email-4">sekar@broadinstitute.org</email>).</p></sec></back></article>
